SEARCH

SEARCH BY CITATION

References

  • 1
    Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736 55.
  • 2
    Müller-Quernheim J. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J 1998; 12: 716 38.
  • 3
    James DG. A worldwide review of sarcoidosis. Ann NY Acad Sci 1976; 276: 335 46.
  • 4
    Rybicki BA, Major M, Popovich J, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145: 234 41.
  • 5
    Wiman LG. Familial occurrence of sarcoidosis. Scand J Resp Dis 1972; 80: 115 9.
  • 6
    Wurm K, Kehler E, Reichelt H. Zur Pathogenese der Sarkoidose (Morbus Boeck): Gehäuftes Sarkoidosevorkommen in tuberkulösen Sippen. Med Klin 1962; 57: 760 4.
  • 7
    Jörgensen G. Die Genetik der Sarkoidose. Acta Med Scand 1964; 425: 209 12.
  • 8
    Haakshorst W. Familiäre Sarkoidose. Thesis, Freiburg, Germany: University Freiburg, 1976.
  • 9
    Kirsten D. Sarkoidose in Deutschland: Analyse einer Fragebogenaktion im Jahre 1992 bei Patienten der Deutschen Sarkoidose Vereinigung. Pneumologie, 1995; 49: 378 85.
  • 10
    Liebermann J. Elevation of serum angiotensin converting enzyme (ACE) level in sarcoidosis. Am J Med 1975; 59: 365 72.
  • 11
    Gilbert S, Steinbrech DS, Landas SK, Hunninghake GW. Amounts of angiotensin-converting enzyme mRNA reflect the burden of granulomas in granulomatous lung disease. Am Rev Resp Dis 1993; 148: 483 6.
  • 12
    Rigat B, Hubert C, Corvol P, Soubrier F. Detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme (DCP1) dipeptidyl carboxypeptidase). Nucl Acid Res 1992; 20: 1433.
  • 13
    Arbustini E, Grasso M, Leo G et al. Polymorphism of angiotensin-converting enzyme in sarcoidosis. Am J Respir Crit Care Med 1996; 153: 851 4.
  • 14
    Sharma P, Smith I, Maguire G et al. Clinical value of ACE genotyping in sarcoidosis. Lancet 1997; 349: 1602 3.
  • 15
    Furuya K, Yamaguchi E, Itoh A et al. Deletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a risk factor for sarcoidosis. Thorax 1996; 51: 777 80.
  • 16
    Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acid Res 1988; 16: 1215.
  • 17
    Lindpainter K, Pfeffer MA, Kreutz R et al. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Eng J Med 1995; 332: 706 11.
  • 18
    Villard E, Tiret L, Visvikis S et al. Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE), and study of their relationship to plasma ACE levels by two QTL segregation-linkage analysis. Am J Hum Genet 1996; 58: 1268 78.
  • 19
    Terwilliger JD & Ott J. Handbook of Human Genetic Linkage. Baltimore, MA: Johns Hopkins Press, 1994.
  • 20
    Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996; 58: 1347 63.
  • 21
    Sham P & Curtis D. An extended transmission/disequilibrium test (TDT) for multi-allele marker loci. Ann Hum Genet 1995; 59: 323 36.
  • 22
    Garrib A, Zhou W, Sherwood R, Peters T. Angiotensin-converting enzyme (ACE) gene polymorphism in patients with sarcoidosis. Biochem Soc Trans 1998; 26: 137.
  • 23
    Maliarik MJ, Rybicki BA, Malvitz E et al. Angiotensin-converting gene polymorphism and risk of sarcoidosis. Am J Resp Crit Care Med 1998; 158: 1566 70.
  • 24
    Pietinalho A, Furuya K, Yamaguchi E, Kawakami Y, Selroos O. The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients. Eur Respir J 1999; 13: 723 6.
  • 25
    Papadopoulos KI, Melander O, Orho-Melander M, Groop LC, Carlsson M, Hallengren B. Angiotensin converting enzyme (ACE) gene polymorphism in sarcoidosis in relation to associated autoimmune diseases. J Intern Med 2000; 247: 71 7.DOI: 10.1046/j.1365-2796.2000.00575.x
  • 26
    Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Sorensen TI, Jensen G, Tybjaerg-Hansen A. ACE gene polymorphism: ischemic heart disease and longevity in 10150 individuals. Circulation 1997; 95: 2358 67.
  • 27
    Maier LA, Raynolds MV, Young DA, Barker EA, Newman LS. Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease. Am J Respir Crit Care Med 1999; 159: 1342 50.
  • 28
    Newman LS. Beryllium disease and sarcoidosis: clinical and laboratory links. Sarcoidosis 1995; 12: 7 19.
  • 29
    Peeters ACTM, Netea MG, Kullberg BJ, Thien T, Van Der Meer JW et al. The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production. Immunology 1998; 94: 376 9.DOI: 10.1046/j.1365-2567.1998.00524.x